Vanda Fights FDA's Refusal To Fast-Track Gastro Drug Review
By Adam Lidgett · May 23, 2022, 6:47 PM EDT
Vanda Pharmaceuticals says the U.S. Food and Drug Administration tried to rewrite the law when it chose not to streamline review of a drug meant to fight nausea in patients with...
To view the full article, register now.